Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.03 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 05/20/15 All times are local (Market data is delayed by at least 15 minutes).

vioquest pharmaceuticals inc (VOQP) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/26/15 - $0.07
52 Week Low
08/14/14 - $0.0070
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

vioquest pharmaceuticals inc (VOQP) Related Businessweek News

No Related Businessweek News Found

vioquest pharmaceuticals inc (VOQP) Details

VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases. Its lead product includes Xyfid, which is under development for the treatment and prevention of hand-foot syndrome. The company’s products also consist of VQD-002, a nucleoside analog that is in Phase I clinical trials for the treatment of cancer; and Lenocta, a small molecule inhibitor of various protein tyrosine phosphatases, which is in Phase IIa clinical trials for the treatment of melanoma, renal cell carcinoma, and other solid tumors. VioQuest Pharmaceuticals also provides chiral products, technology, and custom synthesis development services to pharmaceutical and fine chemical companies in various stages of a products’ lifecycle. The company was founded in 2000 and is headquartered in Basking Ridge, New Jersey.

3 Employees
Last Reported Date: 08/20/08
Founded in 2000

vioquest pharmaceuticals inc (VOQP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VOQP:US $0.03 USD 0.00

VOQP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VOQP.
View Industry Companies

Industry Analysis


Industry Average

Valuation VOQP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIOQUEST PHARMACEUTICALS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at